The Minister of Health of Cyprus, Michalis Hadjipandella, expressed his satisfaction for the actions that led to Cyprus being one of the first countries in the European Union to proceed with the purchase and distribution of the antiviral drug Molnupiravir (Lagevrio).
“Our country now has the specific drug, which contributes to the treatment of the pandemic and protects patients at high risk of severe disease from Covid-19 disease,” said the minister, said Mr. Hadjipandela in a press conference given by the ministry. “As the Ministry of Health, we are constantly on the lookout for new vaccines and new treatments against Covid-19 and are actively involved in all collaborations to ensure that new vaccines are delivered as soon as possible,” he said. but also drugs against Covid-19 “.
For her part, the Deputy Director of Pharmaceutical Services of the Ministry of Health of Cyprus, Dr. Elena Panagiotopoulou, presented the data on Molnupiravir, noting that although it is still in the process of licensing, it has received a recommendation from the European Medicines Agency in the context of emergency disposal, given the protection it has shown to offer through clinical trials carried out. In particular, Molnupiravir has been shown to reduce the risk of serious illness or death in people with Covid-19, from 14.1% in placebo to 7.3% in people taking placebo. Molnupiravir, from a group of 775 participants in total.
Source: ΑΠΕ-ΜΠΕ
.
Source From: Capital
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
